| Dr Nick J Hartl, MD | |
|
412 W 42nd St, Kearney, NE 68845-2401 | |
| (308) 865-2303 | |
| (308) 865-2304 |
| Full Name | Dr Nick J Hartl |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 412 W 42nd St, Kearney, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962416115 | NPI | - | NPPES |
| PENDING | Medicaid | NE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 23781 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Jennie M Melham Memorial Medical Center | Broken bow, NE | Hospital |
| Harlan County Health System | Alma, NE | Hospital |
| Chi Health Good Samaritan | Kearney, NE | Hospital |
| Valley County Health System | Ord, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unmc Physicians | 6002728391 | 1320 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
| Entity Name | Unmc Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417912114 PECOS PAC ID: 6002728391 Enrollment ID: O20031104000664 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
| Entity Name | Heartland Hematology & Oncology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609895713 PECOS PAC ID: 5193619617 Enrollment ID: O20040213000248 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
| Entity Name | Phelps Memorial Health Center |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1629035936 PECOS PAC ID: 9931011947 Enrollment ID: O20071129000753 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
| Entity Name | Phelps Memorial Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871528851 PECOS PAC ID: 9931011947 Enrollment ID: O20080603000111 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nick J Hartl, MD 412 W 42nd St, Kearney, NE 68845-2401 Ph: (308) 865-2303 | Dr Nick J Hartl, MD 412 W 42nd St, Kearney, NE 68845-2401 Ph: (308) 865-2303 |
News Archive
Substantial proportions of parents chose urgent care or emergency department visits when their sick children were excluded from attending child care, according to a new study by University of Michigan researchers.
Caliper Life Sciences, Inc., a leading provider of products and services for drug discovery research, today announced that it has entered into a definitive agreement to acquire privately-held Cambridge Research & Instrumentation, Inc. (CRi) for approximately $20.0 million, including net debt. CRi's patented preclinical and tissue-based multiplexed analysis systems will expand Caliper's life sciences tools portfolio, particularly as it bridges into clinical research, pathology and clinical market applications.
GlaxoSmithKline has come up with an experimental vaccine against tuberculosis (TB) that has shown effective prevention of the infection in half of the population it has been administered to. This could be a breakthrough in preventing the killer disease say researchers since most of the recent vaccines developed against the disease have failed to show efficacy.
HolGenTech, a leader in Genome Computing Architecture, will demonstrate the world's first Personal Genome Assistant (PGA) for the Genome Based Economy at the inaugural event of the Personalized Medicine World Conference at the Mountain View Computer History Museum, January 19-20. Designed to automate best choices for consumers as they shop for food, nutrients, cosmetics and more, the HolGenTech PGA leverages data from genomic tests, health database services, and user preferences to equip consumers with a practical tool to optimize health and maximize prevention.
A team of researchers, led by Dr. Stephan Schwander, of the University of Medicine and Dentistry of New Jersey - School of Public Health (UMDNJ-SPH), has determined a possible link between exposure to a common component of urban air pollution and a change in the function of important immune cells that protect against the bacteria that cause tuberculosis.
› Verified 8 days ago
Ronald Dobesh, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. John S Waters, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 10 E 31st St, Kearney, NE 68847 Phone: 308-865-7100 | |
Dr. Panayotis-alain Efstratiou, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 201, Kearney, NE 68847 Phone: 308-865-7271 | |
Dr. Meenakshi Ghosh, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 200, Kearney, NE 68847 Phone: 308-865-2370 | |
Lissa Woodruff, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. Anub George John, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-7271 Fax: 308-865-2045 | |
Scott Smith, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 816 22nd Ave, Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |